Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01166971 · ClinicalTrials.gov registry record · Phase 4

A Comparison of Visual Function After Bilateral Implantation of Presbyopia-correcting Intraocular Lenses (IOLs)

A Phase 4 study of Cataract, sponsored by Alcon Research.

Completed
Registry status
Phase 4
Development phase
65
Enrollment target
3
Study locations

NCT01166971 is a Phase 4 study of Cataract that has completed, run by Alcon Research. The registered enrollment target is 65 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (71% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01166971, a Phase 4 study of Cataract, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
Phase 4
Development phase
65 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to prospectively evaluate postoperative visual and refractive parameters in a series of subjects bilaterally implanted with the AcrySof® IQ ReSTOR® +3 versus those bilaterally implanted with the Tecnis Multifocal 1-piece.

Conditions Studied

Cataract

Interventions

  • DEVICE ReSTOR +3
  • DEVICE Tecnis MF

Study Locations (3)

Florida

  • The Eye Center of North Florida - Panama City

South Carolina

  • Carolina Eye Care Physicians - Charleston

Texas

  • Whitsett Vision Group - Houston

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2010-07
Phase Phase 4

Sponsor

Alcon Research

275 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01166971

The ClinicalTrials.gov registry entry for NCT01166971 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (71% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 2 interventions - of which ReSTOR +3 is the first listed.

NCT01166971 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, South Carolina, Texas.

Frequently Asked Questions

What is clinical trial NCT01166971 about?

NCT01166971 is a clinical study titled "A Comparison of Visual Function After Bilateral Implantation of Presbyopia-correcting Intraocular Lenses (IOLs)". The purpose of this study is to prospectively evaluate postoperative visual and refractive parameters in a series of subjects bilaterally implanted with the AcrySof® IQ ReSTOR® +3 versus those bilaterally implanted with the Tecnis Multifocal 1-piece.

What is the current status of trial NCT01166971?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 65 participants. The study started on 2010-07.

What conditions does trial NCT01166971 study?

This clinical trial studies the following conditions: Cataract.

What interventions are being tested in trial NCT01166971?

The interventions under investigation include: ReSTOR +3 (DEVICE), Tecnis MF (DEVICE).

Who is sponsoring clinical trial NCT01166971?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01166971 being conducted?

This trial has 3 study locations across Florida, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cataract

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.